欢迎来到天天文库
浏览记录
ID:32287383
大小:3.10 MB
页数:40页
时间:2019-02-02
《黄连膏加散剂外敷治疗皮肤溃疡的临床研究论文》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库。
1、黄连膏加散剂外敷治疗皮肤溃疡的临床研究中文摘要目的观察黄连膏加散剂外敷治疗皮肤溃疡的临床疗效及安全性;观察其在改善皮肤溃疡临床症状及腐肉净化时间、肌生时间、愈合时间的影响。以及进一步研究黄连膏加散剂在临床上治疗皮肤溃疡的作用机理,为临床使用提供理论基础资料。方法1所有病例均为武汉市一医院皮肤科患者,收集2007年1o月-2009年04月门诊和住院部皮肤溃疡患者,符合皮肤溃疡诊断标准63例,采用随机法将病人分为治疗组33例、对照组30例,其中治疗组33例病人中溃疡数目总计有42个,对照组30例病人中溃疡数目总计有33个,经统计学分析,两组病人年龄、性别、病程、溃疡形成原因、溃疡发病部位、
2、溃疡症状组分、溃疡面积及溃疡数目等方面经统计学处理无显著差异(P>O.05),具有可比性。2临床观察分治疗组(黄连膏加散剂组)和对照组(0.1%牙1J凡诺),两组患者有系统疾病的要采取全身用药治疗患者的基础疾病;两组患者局部禁用其他外用药物或治疗方法;两组患者局部清创方法相同。治疗组:患者清创后根据溃疡症状(具体如正文)把散剂直接用棉球点撒于创面,然后视溃疡面积大小把黄连膏涂于无菌纱布上再把涂药后的纱布敷于溃疡面上,外用胶布固定;.对照组:患者清创后用o.1%利凡诺纱条敷于溃疡面上用无菌纱布覆盖。两组患者每日一次换药,且都以15天为1个疗程,3个疗程后进行疗效评定。3观察两组患者治疗前
3、后的临床症状,平均腐肉净化时间,平均肌生时间,平均愈合时间,并作好记录。4安全性观察:观察患者有无不良反应如患者外用本药后有无过敏反应,溃疡面积有无扩湖北中医学院2006届硕士学位论文大,加深。5综合各项指标,将数据用SPSSl6.0统计软件统计学处理,数据总有效率采用X2检验;所有计量资料用;±s(均数±标准差)采用t检验,计算P值。结果1疗效评定:治疗组和对照组,63例溃疡患者中,其中治疗组42个溃疡面中,治愈23个,显效9例,有效率76.18%.对照组治疗33个溃疡面中,治愈9例,显效8例,有效率51.51%.经X2检验分析两组间疗效比较差异有显著性意义(P4、膏加散剂治疗皮肤溃疡优于对照组。2病情评定:在改善溃疡症状、腐肉净化时间、生肌时间、愈合时间上,二组作t检验,其差异有显著性意义(P5、研究ClinicaIresearchof0intmentHuangI-anandpowdertothetreatmentofskinulcersABSTRACTSpeciaIity:DermatoIogyAuthor:HeMeiljnTutor:kongqingyunObjectiveObservationtotheelinicalefficacyandsafetyofointmentHuan91ianandpowdertothetreatmentofskinUleer;ToinvestigatetheimprovementofC1inica1symptomsofskinulcers,6、cartionputificationtime,muscle—shengtimeandhea1ingtime.AndalSOinvestigatingthemechanismofointmentHuanglianandpowdertoskinulcers,providingatheoreticalbasisforelinical.Methods1A11casesareonehospitalinWuhaninpatientSwithskincollectedinMarch2008—2009out—patientandin—patientdepartmentinMarchofpatient7、swithskinulcer,skinulcerin1inewiththediagnosticcriteriafor68cases,thepatientswererandomlydividedintotTeatmentgroup33cases,30casesofcontrolgroup;33casesinwhichtreatmentgroupthenumberofulcerpatientSinatotalof42,30casesofcontro
4、膏加散剂治疗皮肤溃疡优于对照组。2病情评定:在改善溃疡症状、腐肉净化时间、生肌时间、愈合时间上,二组作t检验,其差异有显著性意义(P5、研究ClinicaIresearchof0intmentHuangI-anandpowdertothetreatmentofskinulcersABSTRACTSpeciaIity:DermatoIogyAuthor:HeMeiljnTutor:kongqingyunObjectiveObservationtotheelinicalefficacyandsafetyofointmentHuan91ianandpowdertothetreatmentofskinUleer;ToinvestigatetheimprovementofC1inica1symptomsofskinulcers,6、cartionputificationtime,muscle—shengtimeandhea1ingtime.AndalSOinvestigatingthemechanismofointmentHuanglianandpowdertoskinulcers,providingatheoreticalbasisforelinical.Methods1A11casesareonehospitalinWuhaninpatientSwithskincollectedinMarch2008—2009out—patientandin—patientdepartmentinMarchofpatient7、swithskinulcer,skinulcerin1inewiththediagnosticcriteriafor68cases,thepatientswererandomlydividedintotTeatmentgroup33cases,30casesofcontrolgroup;33casesinwhichtreatmentgroupthenumberofulcerpatientSinatotalof42,30casesofcontro
5、研究ClinicaIresearchof0intmentHuangI-anandpowdertothetreatmentofskinulcersABSTRACTSpeciaIity:DermatoIogyAuthor:HeMeiljnTutor:kongqingyunObjectiveObservationtotheelinicalefficacyandsafetyofointmentHuan91ianandpowdertothetreatmentofskinUleer;ToinvestigatetheimprovementofC1inica1symptomsofskinulcers,
6、cartionputificationtime,muscle—shengtimeandhea1ingtime.AndalSOinvestigatingthemechanismofointmentHuanglianandpowdertoskinulcers,providingatheoreticalbasisforelinical.Methods1A11casesareonehospitalinWuhaninpatientSwithskincollectedinMarch2008—2009out—patientandin—patientdepartmentinMarchofpatient
7、swithskinulcer,skinulcerin1inewiththediagnosticcriteriafor68cases,thepatientswererandomlydividedintotTeatmentgroup33cases,30casesofcontrolgroup;33casesinwhichtreatmentgroupthenumberofulcerpatientSinatotalof42,30casesofcontro
此文档下载收益归作者所有